CONTRATOS ART. 60
Contract
PHASE 1 CONDUCT OF A FEASIBILITY STUDY OF THE IOBA CYTOTES WITH NOVALIQ PRODUCTS.
Funder:
NOVALIQ GMBH
date_range
Duration: from 29 August 2018 to 20 December 2020
(28 months)
Finished
euro
15,000.00 EUR
Of European scope.
